Contents

Current Enzyme Inhibition, Volume 9 - Number 2

Editorial

, 9(2): i

D. Hadjipavlou-Litina


DOI: 10.2174/1573408011309020001




Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue

, 9(2): 83 - 88

Mehmet Agirbasli, Emine Ba s Bozkurtlar, Nurdan Papila-Topal, Hicran Deniz, Betul Ogutmen and Fulya Cakalagaoglu


DOI: 10.2174/1573408011309020002




Targeting Lipoxygenases (LOs): Drug Design And Discovery

, 9(2): 89 - 105

Eleni Pontiki and Dimitra Hadjipavlou–Litina


DOI: 10.2174/1573408011309020003




Identifying the Structural Features of Pyrazolo[4,3-c]Quinoline-3-ones as Inhibitors of Phosphodiesterase 4: An Exploratory CoMFA and CoMSIA Study

, 9(2): 106 - 116

Anand Gaurav and Vertika Gautam


DOI: 10.2174/1573408011309020004




Advances in Design and Development of Inhibitors of Nitric Oxide Synthases

, 9(2): 117 - 141

Harish Kumar, Satya P. Gupta, Anees A. Siddiqui and Vijay Kumar


DOI: 10.2174/1573408011309020005




Laccase Regulators in Anti-fungal Drug Discovery: Dark Lessons from the AIDS-related Pathogen, Cryptococcus

, 9(2): 142 - 151

Jennifer Rabjohns and Peter R. Williamson


DOI: 10.2174/1573408011309020006




Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

, 9(2): 152 - 160

Julie O’Neal and Jason Chesney


DOI: 10.2174/1573408011309020007




The Proteasome as a Therapeutic Target for Lung Fibrosis

, 9(2): 161 - 167

Leonard H.T. Go, Jinal K. Gangar and Manu Jain


DOI: 10.2174/1573408011309020008




Acknowledgements to Reviewers

, 9(2): 168


DOI: 10.2174/1573408011309020009




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science